Posted by Michael Wonder on 10 Jul 2022
Celltrion Pharm's liver disease drug may lose insurance benefits
8 July 2022 - Celltrion's prescription liver disease treatment Godex might lose reimbursement because the HIRA recently decided to withdraw its insurance benefits.
The company appealed the decision immediately.
HIRA disclosed the results of the drug reimbursement review committee's meeting on Thursday.
